723
Views
0
CrossRef citations to date
0
Altmetric
The Pratt-Johnson Lecture

Long-Term Visual Outcomes in Prematurely Born Children

, M.D., FRCSCORCID Icon
Pages 1-8 | Received 21 Nov 2023, Accepted 21 Nov 2023, Published online: 11 Dec 2023

References

  • Teoh LJ, Solebo AL, Rahi JS. British childhood visual I, blindness study interest G. Temporal trends in the epidemiology of childhood severe visual impairment and blindness in the UK. Br J Ophthalmol. 2023;107(5):717–724. doi:10.1136/bjophthalmol-2021-320119.
  • Lim HW, Pershing S, Moshfeghi DM, et al. Causes of childhood blindness in the United States using the IRIS(R) registry (intelligent research in sight). Ophthalmology. 2023;130(9):907–913. doi:10.1016/j.ophtha.2023.04.004.
  • Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS. 2012;16(6):501–507. doi:10.1016/j.jaapos.2012.09.004.
  • Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84(2):77–82. doi:10.1016/j.earlhumdev.2007.11.009.
  • Gilbert C, Malik ANJ, Nahar N, et al. Epidemiology of ROP update - Africa is the new frontier. Semin Perinatol. 2019;43(6):317–322. doi:10.1053/j.semperi.2019.05.002.
  • Gilbert C, Foster A. Childhood blindness in the context of VISION 2020–the right to sight. Bull World Health Organ. 2001;79:227–232.
  • Hartnett ME. Pathophysiology of retinopathy of prematurity. Annu Rev Vis Sci. 2023;9(1):39–70. doi:10.1146/annurev-vision-093022-021420.
  • Chiang MF, Quinn GE, Fielder AR, et al. International classification of retinopathy of prematurity, third edition. Ophthalmology. 2021;128(10):e51–e68. doi:10.1016/j.ophtha.2021.05.031.
  • Yu Y, Tomlinson LA, Binenbaum G, Ying GS, Group GRS. Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort. Br J Ophthalmol. 2021;105(12):1724–1730. doi:10.1136/bjophthalmol-2020-317467.
  • The Canadian Neonatal Network Annual Report 2021. 2021.
  • Dai Y, Zhu L, Zhou Y, et al. Incidence of retinopathy of prematurity treatment in extremely preterm infants in China. Paediatr Perinat Epidemiol. 2022;36(3):380–389. doi:10.1111/ppe.12810.
  • Carrion JZ, Fortes Filho JB, Tartarella MB, Zin A, Jornada ID Jr. Prevalence of retinopathy of prematurity in Latin America. Clin Ophthalmol. 2011;5:1687–1695. doi:10.2147/OPTH.S25166.
  • Xu Y, Zhou X, Zhang Q, et al. Screening for retinopathy of prematurity in China: a neonatal units-based prospective study. Invest Ophthalmol Vis Sci. 2013;54(13):8229–8236. doi: 10.1167/iovs.13-12297.
  • Wilson CM, Ells AL, Fielder AR. The challenge of screening for retinopathy of prematurity. Clin Perinatol. 2013;40(2):241–259. doi:10.1016/j.clp.2013.02.003.
  • Darlow BA, Lui K, Kusuda S, et al. International variations and trends in the treatment for retinopathy of prematurity. Br J Ophthalmol. 2017;101(10):1399–1404. doi:10.1136/bjophthalmol-2016-310041.
  • Lee JW, SilfaMazara F, Olivier A, et al. Retinopathy of prematurity in the Dominican Republic: challenges to screening and prevention. Am J Perinatol. 2012;29(10):801–806. doi:10.1055/s-0032-1316441.
  • Yu CW, Popovic MM, Dhoot AS, et al. Demographic risk factors of retinopathy of prematurity: a systematic review of population-based studies. Neonatology. 2022;119(2):151–163. doi:10.1159/000519635.
  • Popovic MM, Nichani P, Muni RH, Mireskandari K, Tehrani NN, Kertes PJ. Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: a meta-analysis of 3,701 eyes. Surv Ophthalmol. 2021;66(4):572–584. doi:10.1016/j.survophthal.2020.12.002.
  • Baiad AA, Kherani IZ, Popovic MM, et al. A meta-analysis of neurodevelopmental outcomes following Intravitreal Bevacizumab for the treatment of retinopathy of prematurity. Neonatology. 2023:1–12. 10.1159/000531541.
  • Chokron S, Kovarski K, Dutton GN. Cortical visual impairments and learning disabilities. Front Hum Neurosci. 2021;15:713316. doi:10.3389/fnhum.2021.713316.
  • Leung MP, Thompson B, Black J, Dai S, Alsweiler JM. The effects of preterm birth on visual development. Clin Exp Optom. 2018;101(1):4–12. doi:10.1111/cxo.12578.
  • Chang MY, Borchert MS. Advances in the evaluation and management of cortical/cerebral visual impairment in children. Surv Ophthalmol. 2020;65(6):708–724. doi:10.1016/j.survophthal.2020.03.001.
  • Khurana R, Shyamsundar K, Taank P, Singh A. Periventricular leukomalacia: an ophthalmic perspective. Med J Armed Forces India. 2021;77(2):147–153. doi:10.1016/j.mjafi.2020.05.013.
  • Perisset A, Natalucci G, Adams M, Karen T, Bassler D, Hagmann C. Impact of low-grade intraventricular hemorrhage on neurodevelopmental outcome in very preterm infants at two years of age. Early Hum Dev. 2023;177-178:105721. doi:10.1016/j.earlhumdev.2023.105721.
  • van Genderen M, Dekker M, Pilon F, Bals I. Diagnosing cerebral visual impairment in children with good visual acuity. Strabismus. 2012;20(2):78–83. doi:10.3109/09273972.2012.680232.
  • Wenner Y, Kunze K, Lazaridis A, et al. The impact of perinatal brain injury on retinal nerve fiber layer thickness and optic nerve head parameters of premature children. Graefes Arch Clin Exp Ophthalmol. 2023;261(9):2701–2707. doi:10.1007/s00417-023-06069-2.
  • Fiess A, Gissler S, Mildenberger E, et al. Optic nerve head morphology in adults born extreme, very, and moderate preterm with and without retinopathy of prematurity: results from the Gutenberg prematurity eye study. Am J Ophthalmol. 2022;239:212–222. doi:10.1016/j.ajo.2022.03.005.
  • Siatkowski RM, Good WV, Summers CG, Quinn GE, Tung B. Clinical characteristics of children with severe visual impairment but favorable retinal structural outcomes from the Early Treatment for Retinopathy of Prematurity (ETROP) study. Research support, N.I.H., extramural. J AAPOS. 2013;17(2):129–134. doi:10.1016/j.jaapos.2012.10.022.
  • Good WV, Hardy RJ, Dobson V, et al. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2010;128(6):663–671.
  • Hartnett ME, Stahl A. Laser versus anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity. Ophthalmol Ther. 2023;12(5):2241–2252. doi:10.1007/s40123-023-00744-7.
  • Gundlach BS, Kokhanov A, Altendahl M, et al. Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity. Am J Ophthalmol. 2022;238:86–96. doi:10.1016/j.ajo.2021.11.015.
  • Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018;1(1):CD009734. 10.1002/14651858.CD009734.pub3.
  • Murakami T, Okamoto F, Kinoshita T, et al. Comparison of long-term treatment outcomes of laser and anti-VEGF therapy in retinopathy of prematurity: a multicentre study from J-CREST group. Eye (Lond). 2023; 10.1038/s41433-023-02559-z.
  • Jain S, Sim PY, Beckmann J, et al. Functional ophthalmic factors associated with extreme prematurity in young adults. JAMA Netw Open. 2022;5(1):e2145702. doi:10.1001/jamanetworkopen.2021.45702.
  • O’Connor AR, Stephenson T, Johnson A, et al. Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. Pediatrics. 2002;109(1):12–18. doi:10.1542/peds.109.1.12.
  • Chapron T, Pierrat V, Caputo G, et al. Ophthalmological impairments at five and a half years after preterm birth: EPIPAGE-2 cohort study. J Clin Med. 2022;11(8):2139. doi:10.3390/jcm11082139.
  • Garcia-Valenzuela E, Kaufman LM. High myopia associated with retinopathy of prematurity is primarily lenticular. J AAPOS. 2005;9(2):121–128. doi:10.1016/j.jaapos.2004.12.018.
  • Chen TC, Tsai TH, Shih YF, et al. Long-term evaluation of refractive status and optical components in eyes of children born prematurely. Invest Ophthalmol Vis Sci. 2010;51(12):6140–6148. doi:10.1167/iovs.10-5234.
  • Wang Y, Pi LH, Zhao RL, Zhu XH, Ke N. Refractive status and optical components of premature babies with or without retinopathy of prematurity at 7 years old. Transl Pediatr. 2020;9(2):108–116. doi:10.21037/tp.2020.03.01.
  • Quinn GE, Dobson V, Repka MX, et al. Development of myopia in infants with birth weights less than 1251 grams. The cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology. 1992;99(3):329–340. doi:10.1016/s0161-6420(92)31968-2.
  • Hennein L, Koo E, Robbins J, de Alba Campomanes AG. Amblyopia risk factors in premature children in the first 3 years of life. J Pediatr Ophthalmol Strabismus. 2019;56(2):88–94. doi:10.3928/01913913-20190122-02.
  • Kong Q, Ming WK, Mi XS. Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis. BMJ Open. 2021;11(2):e042384. doi:10.1136/bmjopen-2020-042384.
  • Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology. 2002;109(5):936–941. doi:10.1016/s0161-6420(01)01015-6.
  • Quinn GE, Dobson V, Hardy RJ, et al. Visual field extent at 6 years of age in children who had high-risk prethreshold retinopathy of prematurity. Comparative study randomized controlled trial research support, N.I.H., extramural. Arch Ophthalmol. 2011;129(2):127–132. doi:10.1001/archophthalmol.2010.360.
  • Quinn GE, Dobson V, Hardy RJ, Tung B, Phelps DL, Palmer EA. Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial. The CRYO-retinopathy of prematurity cooperative group. Ophthalmology. 1996;103(9):1432–1437. doi:10.1016/s0161-6420(96)30487-9.
  • Quinn GE, Miller DL, Evans JA, Tasman WE, McNamara JA, Schaffer DB. Measurement of Goldmann visual fields in older children who received cryotherapy as infants for threshold retinopathy of prematurity. Arch Ophthalmol. 1996;114(4):425–428. doi:10.1001/archopht.1996.01100130421010.
  • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity. Arch Ophthalmol. 2001;119(8):1129–1133. doi:10.1001/archopht.119.8.1129.
  • McLoone E, O’Keefe M, McLoone S, Lanigan B. Long term functional and structural outcomes of laser therapy for retinopathy of prematurity. Br J Ophthalmol. 2006;90(6):754–759. doi:10.1136/bjo.2005.068304.
  • Petursdottir D, Holmstrom G, Larsson E. Visual function is reduced in young adults formerly born prematurely: a population-based study. Br J Ophthalmol. 2020;104(4):541–546. doi:10.1136/bjophthalmol-2019-314429.
  • VanderVeen DK, Allred EN, Wallace DK, Leviton A, Investigators ES. Strabismus at age 2 years in children born before 28 weeks’ gestation: antecedents and correlates. J Child Neurol. 2016;31(4):451–460. doi:10.1177/0883073815599258.
  • Hreinsdottir J, Ewald U, Strand Brodd K, Ornkloo H, von Hofsten C, Holmstrom G. Ophthalmological outcome and visuospatial ability in very preterm children measured at 2.5 years corrected age. Acta Paediatr. 2013;102(12):1144–1149. doi:10.1111/apa.12406.
  • Holmstrom GE, Kallen K, Hellstrom A, et al. Ophthalmologic outcome at 30 months’ corrected age of a prospective Swedish cohort of children born before 27 weeks of gestation: the extremely preterm infants in Sweden study. JAMA Ophthalmol. 2014;132(2):182–189. doi:10.1001/jamaophthalmol.2013.5812.
  • VanderVeen DK, Bremer DL, Fellows RR, et al. Prevalence and course of strabismus through age 6 years in participants of the early treatment for retinopathy of prematurity randomized trial. J Aapos. 2011;15(6):536–540. doi:10.1016/j.jaapos.2011.07.017.
  • Larsson E, Hellstrom A, Tornqvist K, et al. Ophthalmological outcome of 6.5 years children treated for retinopathy of prematurity: a Swedish register study. Br J Ophthalmol. 2023:bjo-2022–322022. doi:10.1136/bjo-2022-322022.
  • Gulati S, Andrews CA, Apkarian AO, Musch DC, Lee PP, Stein JD. Effect of gestational age and birth weight on the risk of strabismus among premature infants. JAMA Pediatr. 2014;168(9):850–856. doi:10.1001/jamapediatrics.2014.946.
  • Fiess A, Kolb-Keerl R, Schuster AK, et al. Prevalence and associated factors of strabismus in former preterm and full-term infants between 4 and 10 years of age. BMC Ophthalmol. 2017;17(1):228. doi:10.1186/s12886-017-0605-1.
  • Manuchian S, Mireskandari K, Tehrani NN, Isaac M, Robitaille JM. Binocularity outcomes following treatment for retinopathy of prematurity. Can J Ophthalmol. 2021;56(3):179–183. doi:10.1016/j.jcjo.2020.10.007.
  • Petursdottir D, Holmstrom G, Larsson E. Strabismus, stereoacuity, accommodation and convergence in young adults born premature and screened for retinopathy of prematurity. Acta Ophthalmol. 2022;100(3):e791–e797. doi:10.1111/aos.14987.
  • Larsson E, Rydberg A, Holmstrom G. Accommodation and convergence in 10-year-old prematurely born and full-term children: a population-based study. Strabismus. 2012;20(3):127–132. doi:10.3109/09273972.2012.702325.
  • Jung EH, Yu YS, Kim SJ, Awadein A. A comparison of surgical outcomes between pre-and full-term patients with exotropia. PLoS One. 2018;13(12):e0208848. doi:10.1371/journal.pone.0208848.
  • Park KA, Oh SY. Long-term surgical outcomes of infantile-onset esotropia in preterm patients compared with full-term patients. Br J Ophthalmol. 2015;99(5):685–690. doi:10.1136/bjophthalmol-2014-305325.
  • Astudillo PP, Cotesta M, Schofield J, Kraft S, Mireskandari K. The effect of achieving immediate target angle on success of strabismus surgery in children. Am J Ophthalmol. 2015;160(5):913–918. doi:10.1016/j.ajo.2015.07.022.
  • Sardelic E, Utrobicic DK. Long-term variability of strabismus angle in neurologically impaired premature infants: a 12-year follow up. Acta Clin Croat. 2019;58(3):473–480. doi:10.20471/acc.2019.58.03.11.
  • Haugen OH, Nepstad L, Standal OA, Elgen I, Markestad T. Visual function in 6 to 7 year-old children born extremely preterm: a population-based study. Acta Ophthalmol. 2012;90(5):422–427. doi:10.1111/j.1755-3768.2010.02020.x.